Phagyo Bacteriophage – Single Box (4 Vials × 20ml)
Phagyo Bacteriophage – Single Box (4 Vials × 20ml)
Single box for trial or short-term treatment of multi-bacterial infections.
Perfect for testing compatibility or short treatment courses.
- 4 vials × 20ml (80ml total volume)
- Lab-tested quality & standardized production
- Worldwide shipping
- No refrigeration needed until opened (convenient storage)
- Broad-spectrum coverage — 5 bacterial types
Need a full treatment course?
For complete treatment protocols, consider our 5-box treatment course for better value and continuity.
Product overview (general information)
Phagyo bacteriophage is a mixture of sterile filtrates of bacterial phagelysates specifically active against five major pathogenic bacteria. The liquid bacteriophage is a transparent preparation with yellow coloration of various intensity, distributed without prescription.
Manufacturer: JSC "Biochimpharm"
Composition & pharmacological action
Active phage components (each ≥ 10⁵ per ml)
- Bacteriophagum Streptococcus
- Bacteriophagum Staphylococcus
- Bacteriophagum E. coli
- Bacteriophagum Pseudomonas aeruginosa
- Bacteriophagum Proteus
Pharmaceutical form
Sterile liquid in 20 ml bottles, for oral administration, local and external use.
Pharmacological action
Bacteriophages are specific bacterial viruses that are adsorbed on the homological bacterial cell membrane, penetrate into the cell, multiply and cause its lysis. The composition of Phagyo is selective, containing only virulent phages which ensures high activity and effectiveness.
Antibacterial efficacy is based on specific lysis ability of pathogenic bacteria in the infection site. Regardless of administration route, bacteriophage products enter the blood and lymph, reach the infection site, and are excreted mainly by kidneys and partially through the gastrointestinal tract. The product also stimulates the patient's immune system and is efficient in treating diarrheal diseases in immunocompromised patients.
Bacteriophages are strictly specific towards homological bacteria and therefore don't suppress human normal flora and are absolutely safe for human cells.
Activity spectrum & therapeutic applications
Phagyo is used for treatment and prophylaxis of bacterial purulent-inflammatory infections caused by Streptococcus, Staphylococcus, E. coli, Pseudomonas aeruginosa, Proteus and their combinations.
Medicinal product is used in patients of all ages and high-risk groups for treatment of the following diseases:
Respiratory tract infections
- Upper and lower respiratory tract bacterial infections
- Sinusitis, otitis media
- Tonsillitis, pharyngitis, laryngitis
- Tracheitis, bronchitis, pneumonia
- Pleuritis
Surgical infections
- Purulent wounds, burns
- Abscess, phlegmon
- Furuncles, carbuncles, hidradenitis
- Panaritium, paraproctitis
- Mastitis, bursitis, osteomyelitis
Urological & gynecological infections
- Urethritis, cystitis, pyelonephritis
- Colpitis, endometritis
- Salpingo-oophoritis
Gastroenterological conditions
- Enterocolitis, cholecystitis
- Irritable bowel syndrome (IBS)
- Dysbiosis (bacterial overgrowth)
Severe infections
- Generalized septic infections
- Purulent-inflammatory neonatal infections (omphalitis, pyoderma, conjunctivitis, sepsis)
Prophylactic applications
- Treatment of post-surgical and newly infected wounds
- Prevention of purulent complications of surgical procedures
- Prevention of bacterial complications of acute respiratory-viral diseases
- Prevention of bacterial contamination and infections in hospitals
Dosage & usage information (informational)
The following information is provided for general informational purposes only and reflects usage descriptions supplied by the manufacturer. Dosage and application should be determined by qualified professionals based on individual circumstances.
Quick orientation: Treatment duration is typically 5-10 days. One of the most important conditions is to determine phage sensitivity of microorganisms causing disease. Use immediately after opening and store opened vials in refrigerator.
General usage principles
- Determine phage sensitivity of microorganisms before treatment
- Treatment efficacy depends on use at initial stages of disease
- Administer as soon as possible directly to site of infection
- Shake vial before usage
- Content must be transparent and without sediment
- Do not administer turbid preparation
- After usage, store opened vial in refrigerator (do not freeze)
- Treatment duration: 5-10 days
Common application routes (informational)
- Internal use: Oral, rectal (enema)
- Local application: Rinses, irrigation, washing
- Cavity introduction: Wound, abscess, peritoneal cavity, pleural cavity, nose, sinuses, otitis media, bladder, uterus, vagina
Application methods by condition (manufacturer-style informational)
Infected cavities (abscess, wounds):
- Administer after emptying abscess and drainage
- Quantity must be lower than abscess taken from cavity
- Next days: administer through drainage once daily for 3-5 days
- Quantity depends on size of damaged site
Cystitis, pyelonephritis, urethritis:
- Take internally
- If bladder or renal pelvis drained: 20-30 ml into bladder twice daily, 5-10 ml into renal pelvis
Purulent-inflammatory gynecological diseases:
- 5-10 ml into cavity of vagina/uterus once daily
Ear, nose, throat diseases:
- 2-10 ml, 1-3 times daily
- Used for rinsing, washing, or turunda insertion at disease site for 1 hour
- For purulent tonsillitis: use for rinsing and oral administration simultaneously
Stomatitis and chronic generalized periodontitis:
- Mouth rinse 3-4 times daily at 10-20 ml
- Soaked turunda administered into periodontal pockets for 5-10 minutes
Intestinal diseases, IBS (dysbiosis):
- Administered orally and by enema
- Oral: 1 hour before meals
- Enema: once daily, evening, before bedtime
Recommended dosage overview (informational)
| Age group | Oral administration | Per rectum (enema) |
|---|---|---|
| Up to 6 months | 5 ml × 1 per day | 10 ml × 1 per day |
| 6 months to 1 year | 5 ml × 2 per day | 10 ml × 1 per day |
| 1 to 3 years | 5 ml × 3 per day | 20 ml × 1 per day |
| 3 to 8 years | 10 ml × 2-3 per day | 30 ml × 1 per day |
| More than 8 years | 20 ml × 2-3 per day | 40 ml × 1 per day |
Additional notes
- Phagyo is administered for treatment of inflammatory diseases locally and orally at the same time
- Dose for prophylactic use is determined by patient condition
- Preparation can be swallowed during oral cavity treatment
Quality & safety information
Contraindications
Hypersensitivity to any components of preparation.
Side effects
No specific side effects reported.
Drug interactions
No interactions with other medicinal products are known. Preparation can be used together (in combination) with any groups of medicinal products.
Pregnancy and lactation
Preparation can be used during pregnancy and lactation.
Effects on driving and machine operation
There are no indications that preparation may impair the ability to drive or to operate machines.
Special precautions
- Shake vial before usage
- Content must be transparent and without sediment
- Do not administer turbid preparation
- After usage, store opened vial in refrigerator
- Do not freeze the product
- Preparation can be swallowed during oral cavity treatment
- Keep out of reach of children
Packaging & storage
- Package contents: 4 vials × 20ml (80ml total)
- Storage: No refrigeration needed until opened
- After opening: Store in refrigerator (do not freeze)
- Distributed without prescription
Manufacturer:
JSC "Biochimpharm"
Ready to order?
Use the Add to cart button above and proceed to checkout.
Explore related options
- Phagyo Bacteriophage – Treatment Course (5 Boxes) - Better value for complete treatment
- View all bacteriophage products